The Effect Of Alfuzosin And Tolterodine In Treating Double-J Stent-Related Symptoms
Main Category: Urology / NephrologyArticle Date: 15 Jun 2008 - 4:00 PDT
ORLANDO, FL (UroToday.com) - In this Level I prospective randomized study, either alfuzosin (10 mg) or tolterodine (4mg) per day, resulted in a statistically significant equal decrease in ureteral stent symptoms. However, the overall decrease for either drug was only 21%.
Of interest, but understandable, the pain index decreased more with alfuzosin ( a 50% drop) while the symptoms of bladder irritation decreased more with tolterodine (but only by 8-21%). Unfortunately, there was no arm in which both drugs were used.
In sum, among patients undergoing stent placement, complaints of discomfort could likely be addressed with alfuzosin rather than analgesics; unfortunately, complaints of irritative voiding symptoms can not be effectively addressed pharmacologically - for these patients only stent removal is of benefit.
Presented by Seung Chol Park, MD, Jea Whan Lee, MD, Ill Young Se, MD, Hee Jong Jeong, MD, Sang Jin Oh, MD, Joung Sik Rim, MD, and Young Beom Jeong, MD at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Medical Editor Ralph V. Clayman, MD
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |



